CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 56  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0785
LYS 10.0115
GLU 20.0064
LEU 30.0140
ARG 40.0258
CYS 50.0161
GLN 60.0054
CYS 70.0177
ILE 80.0415
LYS 90.0785
THR 100.0312
TYR 110.0107
SER 120.0331
LYS 130.0321
PRO 140.0227
PHE 150.0114
HIS 160.0081
PRO 170.0119
LYS 180.0111
PHE 190.0077
ILE 200.0076
LYS 210.0117
GLU 220.0074
LEU 230.0046
ARG 240.0083
VAL 250.0124
ILE 260.0195
GLU 270.0315
SER 280.0213
GLY 290.0152
PRO 300.0152
HIS 310.0128
CYS 320.0053
ALA 330.0301
ASN 340.0319
THR 350.0253
GLU 360.0084
ILE 370.0075
ILE 380.0053
VAL 390.0067
LYS 400.0061
LEU 410.0046
SER 420.0146
ASP 430.0324
GLY 440.0041
ARG 450.0184
GLU 460.0120
LEU 470.0086
CYS 480.0179
LEU 490.0133
ASP 500.0120
PRO 510.0090
LYS 520.0042
GLU 530.0098
ASN 540.0155
TRP 550.0187
VAL 560.0070
GLN 570.0094
ARG 580.0074
VAL 590.0106
VAL 600.0056
GLU 610.0022
LYS 620.0091
PHE 630.0058
LEU 640.0042
LYS 650.0137
ARG 660.0066
ALA 670.0115
GLU 680.0718
ASN 690.0401

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.